US0906831039
US0906831039
Biote Corp.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 38.98M EUR | 52.28M EUR | 40.48M EUR | 79.85M EUR |
Enterprise Value | 158.05M EUR | 169.75M EUR | 143.58M EUR | 165.65M EUR |
Valuation Multiples | ||||
Trailing P/E | 8.21x | 8.93x | 2.59x | 5.99x |
Forward P/E | 2.56x | -- | -- | -- |
Price to Sales | 0.21x | 0.28x | 0.22x | 0.56x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 0.86x | 0.92x | 0.76x | 1.16x |
EV/EBITDA | 6.2x | 9.13x | 4.38x | 5.78x |
Price to FCF (P/FCF) | -- | 2.98x | 1.53x | 3.37x |
EV/FCF | -- | 9.69x | 5.43x | 6.99x |
FCF Yield | -12.81% | 33.51% | 65.32% | 29.69% |